ACTAVIS LABS FL INC FDA Approval ANDA 205220

ANDA 205220

ACTAVIS LABS FL INC

FDA Drug Application

Application #205220

Documents

Letter2016-07-22

Application Sponsors

ANDA 205220ACTAVIS LABS FL INC

Marketing Status

Prescription001

Application Products

001FOR SOLUTION;ORAL50MG/ML0VALGANCICLOVIR HYDROCHLORIDEVALGANCICLOVIR HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2016-07-18STANDARD
LABELING; LabelingSUPPL2AP2020-03-12STANDARD
LABELING; LabelingSUPPL4AP2020-03-12STANDARD

Submissions Property Types

ORIG1Null15
SUPPL2Null7
SUPPL4Null7

TE Codes

001PrescriptionAB

CDER Filings

ACTAVIS LABS FL INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 205220
            [companyName] => ACTAVIS LABS FL INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"VALGANCICLOVIR HYDROCHLORIDE","activeIngredients":"VALGANCICLOVIR HYDROCHLORIDE","strength":"50MG\/ML","dosageForm":"FOR SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/18\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/205220Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"03\/12\/2020","submission":"SUPPL-4","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"03\/12\/2020","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert, Labeling-Patient Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-03-12
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.